KIR3.1 Antibodies

Santa Cruz Biotechnology delivers a wide array of KIR3.1 monoclonal antibodies for research focused on understanding KIR3.1 protein function. The monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).KIR3.1, also known as Killer-cell Immunoglobulin-like Receptor 3.1, is a crucial component of the immune system, primarily involved in the regulation of natural killer (NK) cell activity. By interacting with specific ligands on target cells, KIR3.1 plays a significant role in modulating immune responses, influencing both the activation and inhibition of NK cells. Understanding KIR3.1 function is essential for advancing research in immunology, cancer therapy, and transplant biology. KIR3.1 monoclonal antibodies enable precise detection and analysis of cellular mechanisms. Researchers can utilize KIR3.1 monoclonal antibodies to explore NK cell regulation and immune system responses. The high specificity of KIR3.1 monoclonal antibodies allows for accurate protein detection and characterization in various experimental settings. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of immune system regulation and potential therapeutic applications.